NHS Blood and Transplant at Cell 2026

Nov 12–13, 2026 London, UK ~800 attendees Website

NHS Blood and Transplant takes part in 2 sessions at Cell 2026 in London. Its sessions centre on getting cell therapies into NHS use and on the regulatory lifecycle of advanced therapies. That regulatory path runs from platform approval through manufacturing to evidence gathered after launch.

OrganizationCell 2026 Attendance
Gov/NGO
NHS body supplying blood, organs, tissues and stem cells in England, with cell, apheresis and gene therapy services.
Talk
Fri Nov 13
12:05pm–12:30pm
Delivering Cell Therapies Into The NHS
Cell and gene therapy
Panel
Fri Nov 13
4:40pm–5:05pm
Navigating The Regulatory Lifecycle Of Advanced Therapies: From Platform Approval To Manufacturing & Post-Market Evidence
with Resolution Therapeutics, Aspen Neuroscience
Cell and gene therapyManufacturing and CMC

Explore the full Cell 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full Cell 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from NHS Blood and Transplant

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction